BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15911426)

  • 1. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus.
    Brestovac B; Harnett GB; Smith DW; Frost F; Shellam GR
    J Clin Virol; 2005 Jun; 33(2):116-22. PubMed ID: 15911426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
    Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
    J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
    Carlson JA; Cribier B; Nuovo G; Rohwedder A
    J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hybrid Capture 2 vs HPV Consensus kit: comparison of 2 assays for human papillomavirus detection and typing].
    Hantz S; Caly H; Decroisette E; Fermeaux V; Bakeland D; Pascal B; Darreye G; Dussartre C; Rogez S; Aubard Y; Denis F; Alain S
    Pathol Biol (Paris); 2005; 53(8-9):556-62. PubMed ID: 16176861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples.
    Ju Z; Yane G; Ding L; Guowu Y; Yanhai G; Yonglan L
    J Clin Virol; 2009 Feb; 44(2):106-10. PubMed ID: 19144564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
    Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
    J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus].
    Ergünay K; Misirlioğlu M; Pinar F; Tuncer ZS; Tuncer S; Ustaçelebi S
    Mikrobiyol Bul; 2007 Apr; 41(2):219-26. PubMed ID: 17682708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
    Schmitt M; Dondog B; Waterboer T; Pawlita M
    J Clin Microbiol; 2008 Mar; 46(3):1050-9. PubMed ID: 18199790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.
    Szostek S; Klimek M; Zawilinska B; Rys J; Kope J; Daszkiewic E
    Acta Biochim Pol; 2006; 53(3):603-7. PubMed ID: 17019439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay.
    Giovannelli L; Lama A; Capra G; Giordano V; Aricò P; Ammatuna P
    J Clin Microbiol; 2004 Aug; 42(8):3861-4. PubMed ID: 15297550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format.
    Kornegay JR; Shepard AP; Hankins C; Franco E; Lapointe N; Richardson H; Coutleé F;
    J Clin Microbiol; 2001 Oct; 39(10):3530-6. PubMed ID: 11574568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high throughout assay for human papillomavirus genotypes with fluorescence polarization.
    Zhang J; Yan X; Sun J; Chen Z; Gao Y; Bai Y; Liu Z
    Chin Med J (Engl); 2003 Aug; 116(8):1137-40. PubMed ID: 12935397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.
    Gillio-Tos A; De Marco L; Ghisetti V; Snijders PJ; Segnan N; Ronco G; Merletti F
    J Clin Virol; 2006 Jun; 36(2):126-32. PubMed ID: 16624614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.
    Albrecht V; Chevallier A; Magnone V; Barbry P; Vandenbos F; Bongain A; Lefebvre JC; Giordanengo V
    J Virol Methods; 2006 Nov; 137(2):236-44. PubMed ID: 16879879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system.
    Broccolo F; Cocuzza CE
    J Virol Methods; 2008 Mar; 148(1-2):48-57. PubMed ID: 18053585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups.
    Leo E; Venturoli S; Cricca M; Musiani M; Zerbini M
    J Clin Virol; 2009 Aug; 45(4):304-10. PubMed ID: 19473874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.